Intimation of 42nd Annual General Meeting, is attached herewith

231/LG/SE/AUG/2026/GBSL August 12, 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 509079 Scrip Symbol: GUFICBIO Subject: Intimation of 42nd Annual General Meeting, Book Closure and Record Date Dear Sir/Madam, With reference to the above captioned subject, we wish to inform that the 42nd Annual General Meeting ("AGM") of the Company is scheduled to be held on Friday, September 04, 2026 at 3:30 p.m. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM) to transact the Ordinary and Special Businesses as set out in the Notice convening the 42nd AGM dated July 31, 2026. A copy of the Notice of 42nd AGM is enclosed herewith. Further, pursuant to the provision of Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Saturday, August 29, 2026 to Friday, September 04, 2026 (both days inclusive) for the purpose of AGM and payment of final dividend for the financial year ended March 31, 2026, if approved by the shareholders at the ensuing 42nd AGM. Intimation of book closure and record date is as below: Scrip Code Type of Book Closure Record Purpose Security From To date BSE: 509079 Equity Saturday, Friday, Friday, Annual General Meeting NSE: GUFICBIO August 29, September August 28, and for payment of final 2026 04, 2026 2026 dividend for FY 2025-26 Kindly take the same on your record. Thanking you, Yours faithfully, For Gufic Biosciences Limited Ami Shah Company Secretary & Compliance Officer Membership No.: A39579 Encl.: As above NOTICE and things and sign agreements, forms, declarations, returns, letters and papers as may be necessary, NOTICE is hereby given that the Forty-Second Annual desirable and expedient to give effect to the said General Meeting (AGM) of the Members of Gufic resolution.” Biosciences Limited will be held on Friday, September 04, 2026 at 3:30 p.m. (IST) through Video Conferencing (VC) / 5. RE-APPOINTMENT OF MR. PANKAJ J. GANDHI (DIN: Other Audio Visual Means (OAVM), to transact the following 00001858) AS WHOLE TIME DIRECTOR OF THE businesses:- COMPANY AND CONTINUATION OF DIRECTORSHIP UPON ATTAINING THE AGE OF 70 YEARS: ORDINARY BUSINESS To consider and if thought fit, to pass with or without 1. To consider and adopt the Audited Standalone Financial modification(s) if any, the following resolution as a Statements of the Company for the financial year ended SPECIAL RESOLUTION: on March 31, 2026 together with Reports of the Board of Directors and Auditor’s thereon and the Audited “RESOLVED THAT pursuant to the provisions of Sections Consolidated Financial Statements of the Company for 152, 196, 197, 198, 203 and any other applicable the financial year ended on March 31, 2026 including provisions of the Companies Act, 2013 (“Act”) and the Auditor’s Report thereon. Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, read with Schedule 2. To declare a Final Dividend @ 10% i.e., ₨ 0.10/- per V to the Act, SEBI (Listing Obligations and Disclosure equity share of the face value of ₨ 1/- each for the Requirements) Regulations, 2015 (including any Financial Year ended March 31, 2026. statutory modification(s) or re-enactment(s) thereof for the time being in force), the Articles of Association of the 3. To appoint a Director in place of Mr. Pranav J. Choksi Company, and subject to such other approvals/ (DIN: 00001731), who retires by rotation pursuant to permissions, as may be required, and pursuant to the Section 152(6) of the Companies Act, 2013 and being recommendation of the Nomination and Remuneration eligible, offers himself for re-appointment. Committee and approval of the Board of Directors, the SPECIAL BUSINESS consent of the Members of the Company be and is hereby accorded for re-appointment of Mr. Pankaj 4. RATIFICATION OF REMUNERATION PAYABLE TO M/S. Jayakumar Gandhi (DIN: 00001858), whose current PODDAR & CO. (FRN: 101734), COST AUDITORS FOR term of office expires on September 06, 2026, and in THE FINANCIAL YEAR 2026-27 respect of whom the Company has received a notice in To consider and if thought fit, to pass with or without writing from a Member proposing his candidature for modification(s) if any, the following resolution as an the office of Director pursuant to Section 160 of the Act, ORDINARY RESOLUTION: as a Whole Time Director of the Company, liable to retire by rotation, for a further period of five (5) “RESOLVED THAT pursuant to Section 148 and other years commencing from September 07, 2026 to applicable provisions, if any, of the Companies Act, 2013 September 06, 2031 (both days inclusive) on the terms read with Companies (Audit and Auditors) Rules, 2014 and conditions as mentioned below and specifically and Companies (Cost Records and Audit) Rules, 2014 approved with powers to the Board of Directors (which (including any statutory modification(s) or re- term shall be deemed to include any committee thereof enactment(s) thereof, for the time being in force), the for the time being and from time to time, to which all or remuneration of ₨ 4,00,000/- per annum plus any of the powers hereby conferred on the Board by this applicable taxes and reimbursement of actual travel and resolution may have been delegated) to alter, amend, out of pocket expenses incurred in connection with the vary and modify the terms and conditions of the said re- audit, as approved by the Board of Directors of the appointment and remuneration payable from time to Company on the recommendation of the Audit time as they deem fit in such manner and within the Committee, for M/s. Poddar & Co. (FRN: 101734), Cost limits prescribed under Schedule V to the said Act or any Accountants, Mumbai, who were appointed as Cost statutory amendment(s) and/or modification(s) Auditors of the Company by the Board of Directors for thereof: conducting audit of the cost records of the Company for the Financial Year ending March 31, 2027, be and is a. Salary:Not exceeding ₨100,00,000/- (Rupees One hereby ratified and approved. Crore) per annum, which shall include the increments that the Board of Directors may decide RESOLVED FURTHER THATthe Board of Directors of the from time to time; Company and the Company Secretary be and are hereby severally authorized to do all such acts, deeds, matters b. Perquisites and allowances: In addition to the THEGLOBALDESTINATION FORINJECTABLES salary, Mr. Pankaj Gandhi shall also be entitled to the continuation of holding of office of Whole Time Director perquisites and allowances like house rent by Mr. Pankaj J Gandhi (DIN: 00001858) beyond the allowance or rent free furnished/non-furnished age of 70 years until the expiry of his aforesaid term on accommodation, house maintenance allowance, September 06, 2031. gas, electricity, water and furnishing at residence, RESOLVED FURTHER THAT the Board of Directors and conveyance allowance, transport allowance, the Company Secretary be and are hereby authorized to medical reimbursement, leave travel allowance and do all such acts, deeds, matters and things as the Board such other allowances, benefits, amenities and may, in its absolute discretion, consider necessary, facilities, as amended from time to time and in expedient or desirable in order to give effect to this accordance with the Company’s policy and the resolution or otherwise considered by the Board to be in Income-Tax Act, 2025 read with rules there the best interest of the Company, as it may deem fit.” under and/or as may be decided by t he Board from time to time; c. Contribution to Provident Fund, Superannuation By order of the Board of Directors Fund, National Pension System, Gratuity as per rules of Gufic Biosciences Limited of the Fund/ Scheme in force from time t [Showing first 8,000 characters — download PDF for full document]